|
21 |
Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease Enthalten in Arquivos de neuro-psiquiatria Bd. 83, 2025, Nr. 05: 001-005
|
|
|
22 |
Efficacy and safety of glucagon-like peptide 1 agonists for Parkinson's disease: a systematic review and meta-analysis Enthalten in Arquivos de neuro-psiquiatria Bd. 83, 2025, Nr. 04: 001-010
|
|
|
23 |
Efficacy and Safety of Fibroblast Growth Factor 21 Analogues for Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis Enthalten in Annals of nutrition & metabolism Bd. 81, 2025, Nr. 1: 51-60. 10 S.
|
|
|
24 |
A Randomized, Controlled Study Evaluating Effects of Saccharomyces boulardii in Adult Patients with Asthma Enthalten in Drug research Bd. 75, 2025, Nr. 05: 162-168
|
|
|
25 |
What does cancer screening have to do with tomato growing? Enthalten in Clinical chemistry and laboratory medicine Bd. 63, 2025, Nr. 7: 1286-1291. 06 S.
|
|
|
26 |
A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study) Enthalten in American journal of nephrology Bd. 56, 2025, Nr. 3: 377-388. 12 S.
|
|
|
27 |
Adjuvante Therapie des Hochrisiko-Urothelkarzinom von Blase oder oberem Harntrakt nach radikaler Resektion Enthalten in Aktuelle Urologie Bd. 56, 2025, Nr. 02: 128-129
|
|
|
28 |
Phosphorus Restriction Prevents Rapamycin-Induced Kidney Damage in Rats Enthalten in American journal of nephrology Bd. 56, 2025, Nr. 1: 48-57. 10 S.
|
|
|
29 |
Off-Label Use of Mycophenolate Mofetil in Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis Enthalten in American journal of nephrology Bd. 56, 2025, Nr. 1: 35-47. 13 S.
|
|
|
30 |
Investigating the Effects of Moxibustion on Gastrointestinal Function and Gut Microbiota in Chronic Renal Failure: A CARE Non-Placebo Randomized Controlled Study in Peritoneal Dialysis Patients Enthalten in Blood purification Bd. 54, 2025, Nr. 6: 289-303. 15 S.
|
|